Global estimates of the prevalence of diabetes for 2010 and 2030

被引:4841
作者
Shaw, J. E. [1 ]
Sicree, R. A. [1 ]
Zimmet, P. Z. [1 ]
机构
[1] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3162, Australia
关键词
Diabetes; Prevalence; Ageing; Urbanization; IMPAIRED GLUCOSE-TOLERANCE; FASTING GLUCOSE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; RISING PREVALENCE; POPULATION SURVEY; URBAN-POPULATION; NATIONAL-HEALTH; US POPULATION;
D O I
10.1016/j.diabres.2009.10.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: We estimated the number of people worldwide with diabetes for the years 2010 and 2030. Methods: Studies from 91 countries were used to calculate age- and sex-specific diabetes prevalences, which were applied to national population estimates, to deter-mine national diabetes prevalences for all 216 countries for 2010 and 2030. Studies were identified using Medline, and contact with all national and regional International Diabetes Federation offices. Studies were included if diabetes prevalence was assessed using a population-based methodology, and was based on World Health Organization or American Diabetes Association diagnostic criteria for at least three separate age-groups within the 20-79 year range. Self-report or registry data were used if blood glucose assessment was not available. Results: The world prevalence of diabetes among adults (aged 20-79 years) will be 6.4%, affecting 285 million adults, in 2010, and will increase to 7.7%, and 439 million adults by 2030. Between 2010 and 2030, there will be a 69% increase in numbers of adults with diabetes in developing countries and a 20% increase in developed countries. Conclusion: These predictions, based on a larger number of studies than previous estimates, indicate a growing burden of diabetes, particularly in developing countries. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:4 / 14
页数:11
相关论文
共 105 条
  • [1] The prevalence and management of diabetes in Thai adults - The International Collaborative Study of Cardiovascular Disease in Asia
    Aekplakorn, W
    Stolk, RP
    Neal, B
    Suriyawongpaisal, P
    Chongsuvivatwong, V
    Cheepudomwit, S
    Woodward, M
    [J]. DIABETES CARE, 2003, 26 (10) : 2758 - 2763
  • [2] Characteristics of patients with type 2 diabetes in Mexico -: Results from a large population-based nationwide survey
    Aguilar-Salinas, CA
    Monroy, OV
    Gómez-Pérez, FJ
    Chávez, AG
    Esqueda, AL
    Cuevas, VM
    Rull-Rodrigo, JA
    Conyer, RT
    [J]. DIABETES CARE, 2003, 26 (07) : 2021 - 2026
  • [3] Diabetes and impaired glucose tolerance in Jordan: prevalence and associated risk factors
    Ajlouni, K
    Jaddou, H
    Batieha, A
    [J]. JOURNAL OF INTERNAL MEDICINE, 1998, 244 (04) : 317 - 323
  • [4] Type II Diabetes Mellitus and impaired glucose tolerance in Yemen: prevalence, associated metabolic changes and risk factors
    Al-Habori, M
    Al-Mamari, M
    Al-Meeri, A
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 65 (03) : 275 - 281
  • [5] Al-Nozha MM, 2004, SAUDI MED J, V25, P1603
  • [6] AlNuaim AR, 1997, DIABETIC MED, V14, P595
  • [7] Diabetes in Ghana: a community based prevalence study in Greater Accra
    Amoah, AGB
    Owusu, SK
    Adjei, S
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 56 (03) : 197 - 205
  • [8] Amos A F, 1997, Diabet Med, V14 Suppl 5, pS1
  • [9] [Anonymous], 2007, WORLD POP PROSP 2006
  • [10] [Anonymous], TECHN REP SER WHO